Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis

Manal F Elshamaa1, Samar Sabry, Mohamed Nabih

  • 1Department of Pediatrics, National Research Center, Elbehoos Street, Dokki, Cairo, Egypt. manal_elshmaa@hotmail.com

Insights

Children on hemodialysis (HD) experience increased oxidative stress and inflammation, indicated by higher malondialdehyde (MDA) and high-sensitivity C-reactive protein (hsCRP) levels. These markers correlate with cardiovascular risks in pediatric patients.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Health
  • Oxidative Stress Research

Background:

  • Children with end-stage renal disease on hemodialysis (HD) face significant oxidative stress.
  • This imbalance impairs antioxidant defenses and elevates oxidative stress markers, contributing to inflammation.

Purpose of the Study:

  • To compare plasma total antioxidant capacity (TAC) and lipid peroxidation products (MDA) in pediatric HD patients versus healthy controls.
  • To investigate the relationship between these oxidative stress markers and high-sensitivity C-reactive protein (hsCRP) in pediatric HD patients.

Main Methods:

  • Plasma TAC, MDA, and hsCRP levels were measured in 30 pediatric HD patients and 20 healthy controls (HC).

Main Results:

  • Pediatric HD patients exhibited significantly higher TAC, MDA, and hsCRP levels compared to HC.
  • A positive correlation was observed between TAC and hsCRP, and MDA and hsCRP in HD patients.

Conclusions:

  • Children on HD show elevated oxidative stress, with MDA levels strongly linked to this susceptibility.
  • Increased hsCRP in HD patients signifies heightened inflammatory activity, potentially explaining cardiovascular complications.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...